Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine , 2021
Obese Class I (30.034.9 kg/m)
They can help you develop a comprehensive plan that addresses weight loss goals, optimal timing for medication discontinuation, strategies for maintaining weight loss after stopping, overall health optimization for pregnancy, and any other medical considerations for conception
Our patient-centered approach puts your preferences and concerns at the forefront, ensuring a collaborative treatment experience
The condition affects around one in 10 women and symptoms include irregular periods, excess body hair and weight gain
Obesity is associated with reduced fertility, increased pregnancy complications, higher risks for both mother and baby, and longer-term health consequences